FSSAI issues warning to nutraceutical companies in Himachal Pradesh
New assay provides enhanced detection of high-priority peanut allergen in a wide variety of matrices
US-based Neogen Corporation has released an enhanced version of the Veratox for Peanut allergen test, which optimises sensitivity and flexibility across sample types while maintaining the rapid time-to-result and simple testing procedure standards set by the Veratox product line.
Neogen’s new Veratox VIP (Veratox Improvement Platform) for Peanut assay is able to rapidly quantify low levels of peanut protein residues in food products, ingredients, and clean-in-place rinses.
This innovative quantitative test utilises the pairing of a unique antibody combination and a modified extraction process to robustly detect levels of peanut protein down to 0.25 ppm. This product has been validated in a wide variety of product types, including both minimally and further-processed products. This flexibility makes the assay appropriate across different food manufacturing and laboratory environments.